GELS

Gelteq Limited

0.7390

+0.0090+1.23%

Pre Market: 0.7032 -0.0358 -4.84%05:44 03/31 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.7030/0.7300

TODAY RANGE0.7013-0.7400

VOL972

MARKET CAP7.92M

52 WEEK RANGE0.6401-4.110

AVG VOL (3M)1.02M

% TURNOVER0.12%

TURNOVER0

P/E (TTM)-1.5971

% RANGE5.30%

EPS(TTM)-0.4627

P/E(FORWARD)--

P/B0.7622

BVPS0.9696

DIVIDEND--

P/S72.45

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.15M

SHARES OUTSTANDING10.71M

NEXT EARNINGS06/22-06/29

FREE FLOAT5.62M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·6d ago
Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance
Reuters·6d ago
Gelteq gets Nasdaq notice after shares trade below $1 for 30 days
Reuters·03/19 00:17
Gelteq Ltd. files initial beneficial ownership statement for Chief Scientific Officer Paul Michael Wynne
Reuters·03/19 00:16
Gelteq Ltd. director Simon Szewach files initial beneficial ownership statement
Reuters·03/18 23:19
Gelteq Ltd. Head of Sales and Marketing Bradley Glenn Karp files initial beneficial ownership statement
Reuters·03/18 23:18
Gelteq Ltd. CEO Nathan J. Givoni files initial beneficial ownership statement
TipRanks·02/11 13:56
Gelteq, Healthy Extracts enter MOU for manufacturing, commercial partnership
Reuters·02/11 13:45
Gelteq and Healthy Extracts Announce Strategic Partnership for Gel-Based Nutraceuticals
Reuters·02/11 13:45
GELTEQ AND HEALTHY EXTRACTS TO EXPAND GEL-BASED NUTRITION TECHNOLOGIES WITH NEW STRATEGIC MANUFACTURING & COMMERCIAL PARTNERSHIP
TipRanks·01/13 14:16
Gelteq announces preclinical results on medicinal cannabinoid absorption
Reuters·01/13 14:01
Gelteq Oral Gel Boosts Medicinal Cannabinoid Absorption in Preclinical Study
Reuters·01/13 14:00
GELTEQ ANNOUNCES POSITIVE PRECLINICAL RESULTS SHOWING INCREASED MEDICINAL CANNABINOID ABSORPTION USING ITS ORAL GEL DELIVERY PLATFORM
Reuters·12/16/2025 14:05
Gelteq Secures $1.3 Million Sales Agreement With Shenzhen Mana Health Management
TipRanks·12/09/2025 20:47
Gelteq Limited Unveils Innovative Drug Delivery Platform in Investor Summit
TipRanks·12/09/2025 14:20
Gelteq entered into three year sales agreement with Mana Health

Same Industry

Name/Symbol

Change%

Price

MCK

BIIB

Amgen Inc

AMGN

-1.24%

348.77

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.96%

886.63

CELG

TXMD

Johnson & Johnson

JNJ

+0.51%

240.45

Abbvie Inc

ABBV

-0.81%

209.40

Zoetis Inc

ZTS

-2.81%

113.35

Gilead Sciences Inc

GILD

+1.56%

136.34

NVO

BMY

ALXN

Pfizer

PFE

-1.92%

27.04

Sanofi FR

SNY

-0.13%

46.72

GCVRZ

Novartis

NVS

-1.02%

148.18

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.